Published in Women's Health Weekly, January 25th, 2001
The trial is the first step in a larger effort to evaluate the efficacy of the InPath System for cervical-cancer screening. Principal investigators for the study include researchers from the Cleveland Clinic Foundation, the Chinese Academy of Medical Sciences, and Kaiser Permanente.
The InPath System is based on the use of biomolecular markers with fluorescent tags to identify abnormal cervical cells. This screening technology includes the use of multiple protein-based probes and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly